Works by Gállego, Jaime


Results: 30
    1

    A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.

    Published in:
    2017
    By:
    • Inogés, Susana;
    • Tejada, Sonia;
    • de Cerio, Ascensión López-Díaz;
    • Pérez-Larraya, Jaime Gállego;
    • Espinós, Jaime;
    • Idoate, Miguel Angel;
    • Domínguez, Pablo Daniel;
    • de Eulate, Reyes García;
    • Aristu, Javier;
    • Bendandi, Maurizio;
    • Pastor, Fernando;
    • Alonso, Marta;
    • Andreu, Enrique;
    • Cardoso, Felipe Prósper;
    • Valle, Ricardo Díez;
    • Gállego Pérez-Larraya, Jaime
    Publication type:
    journal article
    2
    3
    4
    5
    6

    Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00629-1
    By:
    • Cohen, Adam D.;
    • Parekh, Samir;
    • Santomasso, Bianca D.;
    • Pérez-Larraya, Jaime Gállego;
    • van de Donk, Niels W. C. J.;
    • Arnulf, Bertrand;
    • Mateos, Maria-Victoria;
    • Lendvai, Nikoletta;
    • Jackson, Carolyn C.;
    • De Braganca, Kevin C.;
    • Schecter, Jordan M.;
    • Marquez, Loreta;
    • Lee, Erin;
    • Cornax, Ingrid;
    • Zudaire, Enrique;
    • Li, Claire;
    • Olyslager, Yunsi;
    • Madduri, Deepu;
    • Varsos, Helen;
    • Pacaud, Lida
    Publication type:
    Article
    7

    Mass Spectrometry-Based Proteomic Profiling of Thrombotic Material Obtained by Endovascular Thrombectomy in Patients with Ischemic Stroke.

    Published in:
    International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 498, doi. 10.3390/ijms19020498
    By:
    • Muñoz, Roberto;
    • Santamaría, Enrique;
    • Rubio, Idoya;
    • Ausín, Karina;
    • Ostolaza, Aiora;
    • Labarga, Alberto;
    • Roldán, Miren;
    • Zandio, Beatriz;
    • Mayor, Sergio;
    • Bermejo, Rebeca;
    • Mendigaña, Mónica;
    • Herrera, María;
    • Aymerich, Nuria;
    • Olier, Jorge;
    • Gállego, Jaime;
    • Mendioroz, Maite;
    • Fernández-Irigoyen, Joaquín
    Publication type:
    Article
    8
    9
    10

    Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.

    Published in:
    PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0219614
    By:
    • Jablonska, Paola Anna;
    • Diez-Valle, Ricardo;
    • Gállego Pérez-Larraya, Jaime;
    • Moreno-Jiménez, Marta;
    • Idoate, Miguel Ángel;
    • Arbea, Leire;
    • Tejada, Sonia;
    • Eulate, Maria Reyes Garcia de;
    • Ramos, Luis;
    • Arbizu, Javier;
    • Domínguez, Pablo;
    • Aristu, José Javier
    Publication type:
    Article
    11

    Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.

    Published in:
    PLoS ONE, 2019, v. 14, n. 6, p. 1, doi. 10.1371/journal.pone.0217881
    By:
    • Jablonska, Paola Anna;
    • Diez-Valle, Ricardo;
    • Pérez-Larraya, Jaime Gállego;
    • Moreno-Jiménez, Marta;
    • Idoate, Miguel Ángel;
    • Arbea, Leire;
    • Tejada, Sonia;
    • Garcia de Eulate, Maria Reyes;
    • Ramos, Luis;
    • Arbizu, Javier;
    • Domínguez, Pablo;
    • Aristu, José Javier
    Publication type:
    Article
    12
    13
    14
    15

    Neuroprotection in Vascular Dementia.

    Published in:
    Cerebrovascular Diseases, 2006, v. 21, p. 106, doi. 10.1159/000091710
    By:
    • Martínez-Vila, Eduardo;
    • Murie-Fernández, Manuel;
    • Pérez-Larraya, Jaime Gállego;
    • Irimia, Pablo
    Publication type:
    Article
    16
    17
    18

    Dendritic Cells in Cancer Immunology and Immunotherapy.

    Published in:
    Cancers, 2024, v. 16, n. 5, p. 981, doi. 10.3390/cancers16050981
    By:
    • Hato, Laura;
    • Vizcay, Angel;
    • Eguren, Iñaki;
    • Pérez-Gracia, José L.;
    • Rodríguez, Javier;
    • Gállego Pérez-Larraya, Jaime;
    • Sarobe, Pablo;
    • Inogés, Susana;
    • Díaz de Cerio, Ascensión López;
    • Santisteban, Marta
    Publication type:
    Article
    19

    Satisfaction with oral anticoagulants in patients with atrial fibrillation.

    Published in:
    Patient Preference & Adherence, 2018, v. 12, p. 267, doi. 10.2147/PPA.S152109
    By:
    • Fernández, Carmen Suárez;
    • Castilla-Guerra, Luis;
    • Hinojosa, Jesus Cantero;
    • Suriñach, Josep Maria;
    • Bilbao, Fernando Acosta de;
    • Tamarit, Juan José;
    • Diaz, José Luis Diaz;
    • Hernandez, Jose Luis;
    • Pose, Antonio;
    • Montero-Pérez-Barquero, Manuel;
    • Roquer, Jaume;
    • Gállego, Jaime;
    • Vivancos, José;
    • Mostaza, Jose Maria
    Publication type:
    Article
    20
    21
    22
    23

    The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 7, p. 930, doi. 10.1093/neuonc/noy007
    By:
    • Aldave, Guillermo;
    • Gonzalez-Huarriz, Marisol;
    • Rubio, Angel;
    • Romero, Juan Pablo;
    • Ravi, Datta;
    • Miñana, Belén;
    • Cuadrado-Tejedor, Mar;
    • García-Osta, Ana;
    • Verhaak, Roeland;
    • Xipell, Enric;
    • Martinez-Vélez, Naiara;
    • de la Rocha, Arlet Acanda;
    • Puigdelloses, Montserrat;
    • García-Moure, Marc;
    • Marigil, Miguel;
    • Pérez-Larraya, Jaime Gállego;
    • Marín-Bejar, Oskar;
    • Huarte, Maite;
    • Carro, Maria Stella;
    • Ferrarese, Roberto
    Publication type:
    Article
    24

    A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.

    Published in:
    Neuro-Oncology, 2014, v. 16, n. 4, p. 520, doi. 10.1093/neuonc/not218
    By:
    • Manterola, Lorea;
    • Guruceaga, Elizabeth;
    • Pérez-Larraya, Jaime Gállego;
    • González-Huarriz, Marisol;
    • Jauregui, Patricia;
    • Tejada, Sonia;
    • Diez-Valle, Ricardo;
    • Segura, Victor;
    • Samprón, Nicolás;
    • Barrena, Cristina;
    • Ruiz, Irune;
    • Agirre, Amaia;
    • Ayuso, Ángel;
    • Rodríguez, Javier;
    • González, Álvaro;
    • Xipell, Enric;
    • Matheu, Ander;
    • López de Munain, Adolfo;
    • Tuñón, Teresa;
    • Zazpe, Idoya
    Publication type:
    Article
    25
    26

    P-155: Incidence, mitigation, and management of neurologic adverse events in CARTITUDE-2, a phase 2 study of ciltacabtagene autoleucel (cilta-cel) in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S120, doi. 10.1016/S2152-2650(21)02282-5
    By:
    • Einsele, Hermann;
    • Parekh, Samir;
    • Madduri, Deepu;
    • Santomasso, Bianca;
    • Pérez-Larraya, Jaime Gállego;
    • van de Donk, Niels W.C.J.;
    • Arnulf, Bertrand;
    • Mateos, María-Victoria;
    • De Braganca, Kevin C.;
    • Varsos, Helen;
    • Carrasco-Alfonso, Marlene J.;
    • Akram, Muhammad;
    • Lendvai, Nikoletta;
    • Jackson, Carolyn C.;
    • Olyslager, Yunsi;
    • Zudaire, Enrique;
    • Li, Claire;
    • Dong Geng;
    • Jakubowiak, Andrzej;
    • Cohen, Adam
    Publication type:
    Article
    27

    MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S421, doi. 10.1016/S2152-2650(21)01945-5
    By:
    • Jakubowiak, Andrzej;
    • Parekh, Samir;
    • Madduri, Deepu;
    • Santomasso, Bianca;
    • Pérez-Larraya, Jaime Gállego;
    • van de Donk, Niels W.C.J.;
    • Arnulf, Bertrand;
    • Mateos, Maria-Victoria;
    • De Braganca, Kevin C.;
    • Varsos, Helen;
    • Carrasco-Alfonso, Marlene J.;
    • Akram, Muhammad;
    • Lendvai, Nikoletta;
    • Jackson, Carolyn C.;
    • Olyslager, Yunsi;
    • Zudaire, Enrique;
    • Li, Claire;
    • Geng, Dong;
    • Einsele, Hermann;
    • Cohen, Adam
    Publication type:
    Article
    28

    Poster: MM-112: Incidence, Mitigation, and Management of Neurologic Adverse Events in the CARTITUDE-2 Study of Patients with Multiple Myeloma Treated with Ciltacabtagene Autoleucel (Cilta-Cel).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S249, doi. 10.1016/S2152-2650(21)01568-8
    By:
    • Jakubowiak, Andrzej;
    • Parekh, Samir;
    • Madduri, Deepu;
    • Santomasso, Bianca;
    • Pérez-Larraya, Jaime Gállego;
    • van de Donk, Niels W.C.J.;
    • Arnulf, Bertrand;
    • Mateos, Maria-Victoria;
    • De Braganca, Kevin C.;
    • Varsos, Helen;
    • Carrasco-Alfonso, Marlene J.;
    • Akram, Muhammad;
    • Lendvai, Nikoletta;
    • Jackson, Carolyn C.;
    • Olyslager, Yunsi;
    • Zudaire, Enrique;
    • Li, Claire;
    • Geng, Dong;
    • Einsele, Hermann;
    • Cohen, Adam
    Publication type:
    Article
    29
    30